NEW YORK, Aug. 22, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of HD Supply Holdings, Inc. (NASDAQ:HDS) from November 9, 2016 through June 5, 2017, inclusive (the “Class Period”) of the important September 11, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for HD Supply investors under the federal securities laws.
To join the HD Supply class action, go to http://rosenlegal.com/cases-1161.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The complaint alleges that defendants during the Class Period made false and misleading statements and/or failed to disclose that: (1) HD Supply’s full year 2017 growth and operational leverage targets were unattainable; (2) the operational recovery of its Facilities Maintenance supply chain was not going according to plan; (3) HD Supply was exploring the sale of its Waterworks segment; (4) Defendant Joseph DeAngelo, with full knowledge of the undisclosed materially adverse facts alleged herein, embarked on a selling spree of personal holdings of HD Supply stock that netted him over $54 million in proceeds; and (5) as a result of the foregoing, Defendants’ statements about HD Supply’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 11, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1161.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



